| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-10-14 |
4 |
AS |
$4.20 |
$16,800 |
D/D |
(4,000) |
494,723 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-10-13 |
4 |
AS |
$4.20 |
$16,800 |
D/D |
(4,000) |
498,723 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-10-12 |
4 |
AS |
$4.13 |
$21,700 |
D/D |
(5,200) |
502,723 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-10-11 |
4 |
AS |
$4.11 |
$11,580 |
D/D |
(2,800) |
507,923 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-09-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
510,723 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2010-08-10 |
4 |
S |
$3.76 |
$46,768 |
D/D |
(12,300) |
71,200 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2010-07-01 |
4 |
D |
$4.22 |
$1,675 |
D/D |
(397) |
26,917 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-06-11 |
4 |
S |
$4.02 |
$83,528 |
I/I |
(20,760) |
0 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-06-04 |
4 |
S |
$4.01 |
$59,288 |
I/I |
(14,775) |
20,760 |
|
- |
|
| Comstock Allan L |
Director |
– • – |
2010-06-03 |
4 |
OE |
$4.00 |
$46,052 |
D/D |
11,513 |
21,732 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-06-03 |
4 |
OE |
$4.00 |
$46,052 |
D/D |
11,513 |
132,822 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-06-03 |
4 |
S |
$4.00 |
$8,001 |
I/I |
(2,000) |
35,535 |
|
- |
|
| Tunstall Kathryn |
Director |
– • – |
2010-06-03 |
4 |
OE |
$4.00 |
$46,052 |
D/D |
11,513 |
20,732 |
|
- |
|
| Milligan David V |
Director |
– • – |
2010-06-03 |
4 |
OE |
$4.00 |
$46,052 |
D/D |
11,513 |
20,732 |
|
- |
|
| Bishop Robert C |
Director |
– • – |
2010-06-03 |
4 |
OE |
$4.00 |
$65,788 |
D/D |
16,447 |
27,852 |
|
- |
|
| Billet Van |
Director |
– • – |
2010-06-03 |
4 |
OE |
$4.00 |
$46,052 |
D/D |
11,513 |
20,732 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-06-02 |
4 |
S |
$4.01 |
$9,624 |
I/I |
(2,400) |
37,535 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-05-28 |
4 |
S |
$4.00 |
$12,011 |
I/I |
(3,000) |
39,935 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2010-05-24 |
4 |
S |
$4.02 |
$69,866 |
I/I |
(17,400) |
42,935 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2010-03-29 |
4 |
D |
$3.94 |
$4,066 |
D/D |
(1,032) |
111,111 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2010-03-29 |
4 |
D |
$3.94 |
$4,700 |
D/D |
(1,193) |
71,500 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2010-03-29 |
4 |
D |
$3.94 |
$3,128 |
D/D |
(794) |
516,723 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2010-03-29 |
4 |
D |
$3.94 |
$1,564 |
D/D |
(397) |
66,130 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2010-03-29 |
4 |
D |
$3.94 |
$4,700 |
D/D |
(1,193) |
68,967 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2010-03-16 |
4 |
D |
$3.65 |
$1,847 |
D/D |
(506) |
26,064 |
|
- |
|
291 Records found
|
|
Page 4 of 12 |
|
|
